FRESENIUS KABI COLOMBIA SAS — Docetaxel Importer Profile
Pharmaceutical Importer · #7 buyer for Docetaxel · $917.3K import value · 28 shipments · COLOMBIA · DGFT Verified
FRESENIUS KABI COLOMBIA SAS is the #7 importer of Docetaxel from India with $917.3K in import value and 28 verified shipments. FRESENIUS KABI COLOMBIA SAS holds a 2.8% market share in Docetaxel imports based in COLOMBIA. The company sources from 1 verified supplier across 23 formulations shipped to 1 country. Overall, FRESENIUS KABI COLOMBIA SAS imports 4 pharmaceutical products worth $3.7M across 2 therapeutic categories.
FRESENIUS KABI COLOMBIA SAS — Docetaxel Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Docetaxel to FRESENIUS KABI COLOMBIA SAS?
Verified from 28 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | $917.3K | 28 | 100.0% |
FRESENIUS KABI COLOMBIA SAS sources Docetaxel from 1 verified Indian supplier based on 28 customs records. The primary supplier is FRESENIUS KABI ONCOLOGY LIMITED accounting for 100.0% of imports.
How Does FRESENIUS KABI COLOMBIA SAS Compare to Nearest Docetaxel Importers?
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN INSTITUTIONAL INC 2898 | UNITED STATES | $3.3M | 65 | $50.0K |
| 3 | FRESENIUS KABI DEUTSCHLAND GMBH | GERMANY | $2.5M | 144 | $17.5K |
| 7 | FRESENIUS KABI COLOMBIA SAS ★ | COLOMBIA | $1.1M | 28 | $39.1K |
| 10 | CPC "BIOCON" LLC | UKRAINE | $707.3K | 18 | $39.3K |
| 5 | J. KNIPPER & COMPANY | UNITED STATES | $600.0K | 12 | $50.0K |
FRESENIUS KABI COLOMBIA SAS ranks #7 among 641 Docetaxel importers from India. Average shipment value of $39.1K compared to the market average of $19.4K. The closest competitors by value are MYLAN INSTITUTIONAL INC 2898 and FRESENIUS KABI DEUTSCHLAND GMBH.
Where Does FRESENIUS KABI COLOMBIA SAS Import Docetaxel To?
Destination countries from 28 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| COLOMBIA | $917.3K | 28 | 100.0% |
FRESENIUS KABI COLOMBIA SAS imports Docetaxel to 1 country. The primary destination is COLOMBIA receiving 100.0% of shipments worth $917.3K.
What Docetaxel Formulations Does FRESENIUS KABI COLOMBIA SAS Import?
| Formulation | Value | Shipments |
|---|---|---|
| DOCETAXEL INJ 20MG 1ML VIAL BATCH NO 87250114AA MFG DT 04 2025 EXP DT 03 2027 5963 VIALS | $102.9K | 3 |
| DOCETAXEL INJ 80MG/4ML VIAL BATCH NO.87240485BA, MFG. DT. 11/2024, EXP. DT. 10/2026 | $100.0K | 2 |
| DOCETAXEL INJECTION 80MG/4ML VIAL BATCH | $97.7K | 2 |
| DOCETAXEL INJ. 80MG/4ML VIAL BATCH NO. 8 | $69.2K | 2 |
| DOCETAXEL INJ. 80MG/4ML VIAL. B/N: 87220 | $50.0K | 1 |
| DOCETAXEL INJ. 80MG/4ML VIAL BATCH NO. 87230402BA MANUFACTURING . DT. 08/2023 EXP. DT. 07/2025 | $50.0K | 1 |
| DOCETAXEL INJ. 80MG/4ML VIAL, BATCH NO.87240157AC, MFG. DT. 04/2024, EXP. DT.03/2026 | $50.0K | 1 |
| DOCETAXEL INJ. 80MG/4ML VIAL (BATCH NO.87250103AB, MFG. DT. 03/2025, EXP. DT. 02/2027) | $50.0K | 1 |
| DOCETAXEL INJ.80MG/4ML VIALBATCH NO.87230427BA MANUFACTURING .DT.09/2023 & EXP.DT.08/2025 | $46.3K | 1 |
| DOCETAXEL INJ. 80MG/4ML VIAL BATCH NO. 87240 023BAMFG. DT. 01/2024 EXP. DT. 12/2025NOS | $36.7K | 1 |
FRESENIUS KABI COLOMBIA SAS imports 23 distinct Docetaxel formulations from India. The top formulation is DOCETAXEL INJ 20MG 1ML VIAL BATCH NO 87250114AA MFG DT 04 20 with 3 shipments worth $102.9K.
Who Are the Top Buyers of Docetaxel from India and How Much Does FRESENIUS KABI COLOMBIA SAS Import?
India exported $12.4M worth of Docetaxel through 2,634 shipments from 253 suppliers to 120 countries, serving 641 buyers globally. FRESENIUS KABI COLOMBIA SAS imports $917.3K of this total, accounting for 2.8% of India's Docetaxel exports with 28 shipments from COLOMBIA. This is verified from 28 customs shipment records covering 23 distinct formulations.
What Is the Average Order Value for FRESENIUS KABI COLOMBIA SAS's Docetaxel Imports?
FRESENIUS KABI COLOMBIA SAS's average Docetaxel order value is $32.8K per consignment, based on 28 shipments totaling $917.3K. FRESENIUS KABI COLOMBIA SAS is based in COLOMBIA and ranks #7 among all Docetaxel importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Docetaxel to FRESENIUS KABI COLOMBIA SAS?
FRESENIUS KABI COLOMBIA SAS sources Docetaxel from 1 verified Indian supplier: FRESENIUS KABI ONCOLOGY LIMITED ($917.3K, 100.0%). This is based on 28 customs records.
How Does FRESENIUS KABI COLOMBIA SAS Compare to Other Docetaxel Importers?
FRESENIUS KABI COLOMBIA SAS ranks #7 among 641 Docetaxel importers from India with a 2.8% market share. The top 3 importers are MYLAN INSTITUTIONAL INC 2898 ($3.3M), FRESENIUS KABI DEUTSCHLAND GMBH ($2.5M), FRESENIUS KABI COLOMBIA SAS ($1.1M). FRESENIUS KABI COLOMBIA SAS processed 28 shipments from COLOMBIA.
What Other Oncology Products Does FRESENIUS KABI COLOMBIA SAS Import?
FRESENIUS KABI COLOMBIA SAS also imports these oncology products. Each links to the detailed product page.
About FRESENIUS KABI COLOMBIA SAS
FRESENIUS KABI COLOMBIA SAS imports 4 products worth $3.7M. Beyond Docetaxel, top products include Paclitaxel, Oxaliplatin, Carboplatin. View the complete FRESENIUS KABI COLOMBIA SAS profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Docetaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Docetaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: FRESENIUS KABI COLOMBIA SAS matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as FRESENIUS KABI COLOMBIA SAS's capped import value divided by total capped export value for Docetaxel across all Indian exporters.
- 5.Verified Records: This page is backed by 28 individual customs records matching FRESENIUS KABI COLOMBIA SAS importing Docetaxel, covering 23 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 120+ countries, 641+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Docetaxel Import Data for FRESENIUS KABI COLOMBIA SAS
Access order-level details, pricing data, supplier connections, and competitive analysis for FRESENIUS KABI COLOMBIA SAS's Docetaxel imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FRESENIUS KABI COLOMBIA SAS
Full Company Profile →
4 products · $3.7M total trade · 2 categories
FRESENIUS KABI COLOMBIA SAS × Docetaxel
Verified from customs records
Company Overview
Top Products by FRESENIUS KABI COLOMBIA SAS
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for FRESENIUS KABI COLOMBIA SAS.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Docetaxel. For current order-level data, contact TransData Nexus.